Day One Biopharmaceuticals's total assets for Q3 2023 were $414.18M, a decrease of -8.11% from the previous quarter. DAWN total liabilities were $24.55M for the fiscal quarter, a -0.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.